by Stephen Suplita | Jun 11, 2018
– Published in the Lancet Global Health Volume 6, No. 6, e609–e610, June 2018 Drug prices are controversial in all countries, and nowhere more so than in low-income and middle-income countries, where access to essential drugs is very price sensitive. The higher the...
by Stephen Suplita | Apr 2, 2018
The Eastern Europe and Central Asia AIDS Conference took place in Moscow, Russia, from April 18 to 20, 2018. The concept of the conference was: “Mobilizing resources: experience, investments, innovations.” The objective of the conference was to develop regional...
by Sinette Goosen | Feb 12, 2018
The generic antiretroviral (ARV) market will be in a state of transition in 2018 with the introduction of a new fixed-dose combination (FDC) to serve as an alternative first-line treatment for adults. The product, known as “TLD,” is a single pill comprised of...
